Showing results (111-120 of 173) with videos related to

Sort By:
Pageof 18
Archives of General Psychiatry|February 1, 1982
High doses of haloperidol in schizophrenia. A clinical, biochemical, and pharmacokinetic studyE Zarifian, B Scatton, G Bianchetti, et al.
L'Encephale|January 1, 1982
[Use of haloperidol in high doses in schizophrenia. Clinical, biochemical and pharmacokinetic study]B Scatton, E Zarifian, G Bianchetti, et al.
L'Encephale|April 6, 2013
[Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report]G Huguet, A Lillo-Le Louet, L Darnige, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|August 10, 2004
Photochromism of novel molybdate/alkylamine composite thin filmsZhaohui Chen, Boon H Loo, Ying Ma, et al.
Journal of Affective Disorders|December 19, 1998
Gender, temperament, and the clinical picture in dysphoric mixed mania: findings from a French national study (EPIMAN)H S Akiskal, E G Hantouche, M L Bourgeois, et al.
Acta Neuropathologica|January 1, 1981
Purkinje cell dendritic development in experimental phenylketonuria. A quantitative analysisO Robain, G Y Wen, H M Wisniewski, et al.
Psychopharmacology|January 1, 1986
Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depressionB Scatton, H Loo, T Dennis, et al.
The Journal of Urology|December 1, 1986
Effect of thromboxane inhibition on renal blood flow in dogs with complete unilateral ureteral obstructionM H Loo, D N Marion, E D Vaughan, et al.
Developmental Neuroscience|January 1, 1983
Experimental maternal phenylketonuria: an examination of two animal modelsY H Loo, A Rabe, A Potempska, et al.
The Medical Journal of Malaysia|December 2, 2025
Prevalence, risk factors and etiologies of onychomycosis in patients with psoriasisE S Law, C H Loo, W C Tan, et al.
Pageof 18